These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3018893)

  • 1. Infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus: considerations for transmission in the child day care setting.
    MacDonald KL; Danila RN; Osterholm MT
    Rev Infect Dis; 1986; 8(4):606-12. PubMed ID: 3018893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome.
    Kaplan JE; Oleske JM; Getchell JP; Kalyanaraman VS; Minnefor AB; Zabala-Ablan M; Joshi V; Denny T; Cabradilla CD; Rogers MF
    Pediatr Infect Dis; 1985; 4(5):468-71. PubMed ID: 2995933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natural history of infection with the lymphadenopathy-associated virus/human T-lymphotropic virus type III.
    Francis DP; Jaffe HW; Fultz PN; Getchell JP; McDougal JS; Feorino PM
    Ann Intern Med; 1985 Nov; 103(5):719-22. PubMed ID: 2996406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 May; 35(20):334-9. PubMed ID: 3010072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam.
    Coutinho RA; Krone WJ; Smit L; Albrecht-van Lent P; van der Noordaa J; Schaesberg W; Goudsmit J
    Genitourin Med; 1986 Feb; 62(1):38-43. PubMed ID: 3005159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody to human T-lymphotropic virus type III in wives of hemophiliacs. Evidence for heterosexual transmission.
    Kreiss JK; Kitchen LW; Prince HE; Kasper CK; Essex M
    Ann Intern Med; 1985 May; 102(5):623-6. PubMed ID: 2984972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of human T-cell lymphotropic virus type III infection in children. Recognition of symptomatic, asymptomatic, and seronegative patients.
    Pahwa S; Kaplan M; Fikrig S; Pahwa R; Sarngadharan MG; Popovic M; Gallo RC
    JAMA; 1986 May; 255(17):2299-305. PubMed ID: 3007791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM).
    Kanki PJ; Barin F; M'Boup S; Allan JS; Romet-Lemonne JL; Marlink R; McLane MF; Lee TH; Arbeille B; Denis F
    Science; 1986 Apr; 232(4747):238-43. PubMed ID: 3006256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men.
    Jaffe HW; Feorino PM; Darrow WW; O'Malley PM; Getchell JP; Warfield DT; Jones BM; Echenberg DF; Francis DP; Curran JW
    Ann Intern Med; 1985 May; 102(5):627-8. PubMed ID: 2984973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of children infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Recommendations of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1987 Jan; 106(1):75-8. PubMed ID: 3024547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting seropositivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDS.
    Weber JN; McCreaner A; Berrie E; Wadsworth J; Jeffries DJ; Pinching AJ; Harris JR
    Genitourin Med; 1986 Jun; 62(3):177-80. PubMed ID: 3015772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occupational risk of the acquired immunodeficiency syndrome among health care workers.
    McCray E
    N Engl J Med; 1986 Apr; 314(17):1127-32. PubMed ID: 3485769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HTLV-III/LAV and resuscitation].
    Kroegel C; Hess G; Meyer zum Büschenfelde KH
    Dtsch Med Wochenschr; 1986 Mar; 111(12):476-7. PubMed ID: 3004880
    [No Abstract]   [Full Text] [Related]  

  • 15. Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome.
    Fultz PN; McClure HM; Swenson RB; McGrath CR; Brodie A; Getchell JP; Jensen FC; Anderson DC; Broderson JR; Francis DP
    J Virol; 1986 Apr; 58(1):116-24. PubMed ID: 3005641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of nosocomial infection with human T-cell lymphotropic virus type III/lymphadenopathy-associated virus in a large cohort of intensively exposed health care workers.
    Henderson DK; Saah AJ; Zak BJ; Kaslow RA; Lane HC; Folks T; Blackwelder WC; Schmitt J; LaCamera DJ; Masur H
    Ann Intern Med; 1986 May; 104(5):644-7. PubMed ID: 3963663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia.
    Jason JM; McDougal JS; Dixon G; Lawrence DN; Kennedy MS; Hilgartner M; Aledort L; Evatt BL
    JAMA; 1986 Jan; 255(2):212-5. PubMed ID: 3001375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterosexually acquired HTLV-III/LAV disease (AIDS-related complex and AIDS). Epidemiologic evidence for female-to-male transmission.
    Redfield RR; Markham PD; Salahuddin SZ; Wright DC; Sarngadharan MG; Gallo RC
    JAMA; 1985 Oct; 254(15):2094-6. PubMed ID: 2995695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
    Yarchoan R; Redfield RR; Broder S
    J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).
    Nicholson JK; Cross GD; Callaway CS; McDougal JS
    J Immunol; 1986 Jul; 137(1):323-9. PubMed ID: 3011909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.